The Pangaea Global AIDS Foundation

About Us
The Pangaea Global AIDS Foundation was established by the San Francisco AIDS Foundation on World AIDS Day, 2001. Pangaea’s primary goals are to broaden access to HIV/AIDS antiretroviral (ARV) treatment and care in developing countries and to support the development of an effective HIV vaccine.

Projects
In its first three years, Pangaea has partnered with the William Jefferson Clinton Foundation to assist the governments of China, South Africa, Rwanda, and the Bahamas in the development and implementation of countrywide plans for providing HIV/AIDS care and treatment, including ARVs. In China, for example, Pangaea began work in May 2004 as a partner in the William Jefferson Clinton Foundation's HIV/AIDS Initiative. Pangaea's role has been to provide technical assistance to the Ministry of Health in support of expanding a national program for HIV/AIDS care and treatment. Pangaea professionals are providing assistance in a number of areas, including the development of national treatment guidelines for use of antiretroviral therapies, clinical training of health professionals and planning for a national scale-up of training, and development of systems for monitoring and evaluation.

In Uganda, Pangaea has partnered with Pfizer Inc, Makerere University and the Academic Alliance for AIDS Care and Prevention in Africa, an organization of North American and Ugandan physicians, to build a state-of-the-art HIV/AIDS training center and clinic, which opened in August 2004. Pangaea provides construction oversight, as well as fiscal and administrative management support for all phases of the project.

Pangaea is dedicated to helping developing countries expand their existing health care systems so that they are able to provide sustainable, comprehensive HIV care and treatment, including ARVs, to all people with HIV/AIDS.

Call to Action
According to UNAIDS.org, approximately 40 million people are currently living with HIV/AIDS throughout the world, and 95 percent of these individuals reside in the developing world. About 5 million people were infected with HIV in 2003 and more than 3 million died. HIV/AIDS has orphaned 10 million children, and 33 million more will be orphaned by the end of the decade if decisive action is not taken. At current rates of infection, it is projected that the number of people with HIV will more than double by the year 2010. In most developing countries between 15 to 40% of working adults are HIV positive. National governments around the world are beginning to respond to the crisis, but they will need an unprecedented level of help from the global community to counter the devastating effects of the pandemic.

Treatment Offers Hope
In the midst of this tragedy, there is hope. With the development of antiretroviral treatments, HIV/AIDS is no longer a death sentence. ARVs allow many people with HIV/AIDS to maintain their health and quality of life, and extend their life expectancy. The prospect of effective treatment is the greatest antidote to the stigma and fear that surround AIDS and is also the greatest incentive to be tested or get counseling, and, therefore, the critical component of any HIV prevention initiative. Unfortunately, less than one percent of those who need ARVs in Africa are currently receiving them.

Though ARVs are becoming more accessible and affordable, the capacity for treating large numbers of HIV/AIDS patients with ARVs and other life-sustaining treatments is still very limited in most developing countries. Inadequate funding, overburdened systems of care, inadequate support services, and shortage of trained personnel are among many of the daunting challenges. For HIV/AIDS treatment to be delivered effectively in developing countries, a strong commitment must be made to improve existing healthcare infrastructure.

Pangaea’s Unique Role
With extensive experience in HIV/AIDS care and treatment, Pangaea’s staff focuses its expertise on developing short and long-range plans to develop and scale up HIV/AIDS treatment capacity, focused on the delivery of ARVs, within existing health care delivery systems. To ensure that its work is effective, Pangaea is committed to ensuring that its partnerships result in health care delivery models that utilize and build on local capacity and are sustainable for the long-term, culturally relevant and sensitive, developed with the involvement of people with HIV/AIDS, and supported by strong management systems.

To achieve Pangaea’s primary goal of broadening access in developing countries to life-sustaining treatment and care, the foundation is currently:

* Working with developing country partners to help plan, design and scale up comprehensive HIV treatment and care systems that include ARVs within existing local, regional and national healthcare delivery structures.
* Providing technical assistance in the design and implementation of management infrastructure within broad-based HIV treatment and care delivery programs, including supervisory, fiscal, human resources and communications systems.
* Expanding in-country partner training capacity to increase pools of physicians, nurses and other health providers who can deliver care and treatment services; and
* Assisting in the design and implementation of broad-based monitoring and evaluation systems to measure effectiveness and outcomes of HIV treatment and care delivery systems.

How You Can Help
Pangaea’s focus on building sustainable and replicable programs has placed its experts at the forefront of the global battle against AIDS. To find out how you and your organization can help Pangaea expand and build upon these efforts, call Pangaea at 415-581-7000 or send an e-mail to info@pgaf.org.